Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The 2017 Bethesda System For Reporting Thyroid Cytopathology.

E. Cibas, S. Ali
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) established a standardized, category-based reporting system for thyroid fine-needle aspiration (FNA) specimens. The 2017 revision reaffirms that every thyroid FNA report should begin with 1 of 6 diagnostic categories, the names of which remain unchanged since they were first introduced: (1) Nondiagnostic or Unsatisfactory; (2) Benign; (3) Atypia of Undetermined Significance (AUS) or Follicular Lesion of Undetermined Significance (FLUS); (4) Follicular Neoplasm or Suspicious for a Follicular Neoplasm; (5) Suspicious for Malignancy; and (6) Malignant. There is a choice of two different names for some of the categories: a laboratory should choose the one it prefers and use it exclusively for that category; synonymous terms (eg, AUS and FLUS) should not be used to denote 2 distinct interpretations. Each category has an implied cancer risk that ranges from 0% to 3% for the "Benign" category to virtually 100% for the "Malignant" category, and, in the 2017 revision, the malignancy risks have been updated based on new (post 2010) data. As a function of their risk associations, each category is linked to updated, evidence-based clinical management recommendations. The recent reclassification of some thyroid neoplasms as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has implications for the risk of malignancy, and this is accounted for with regard to diagnostic criteria and optional notes. Such notes can be useful in helping guide surgical management.
This paper references
10.1002/cncy.21769
Coming to terms with NIFTP: A provisional approach for cytologists
J. Krane (2016)
10.1159/000334214
Timing of Repeat Thyroid Fine-Needle Aspiration in the Management of Thyroid Nodules
R. Singh (2011)
10.1089/thy.2009.0274
The Bethesda System for Reporting Thyroid Cytopathology.
E. Cibas (2009)
The Bethesda system for reporting thyroid cytopathology : definitions, criteria, and explanatory notes
S. Ali (2010)
10.1002/dc.21492
Histologic follow‐up of nondiagnostic thyroid fine needle aspirations: Implications for adequacy criteria
A. Renshaw (2012)
10.1002/cncy.21858
Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only
M. Vivero (2017)
10.1159/000451020
The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel
M. Pusztaszeri (2016)
10.1002/cncr.10715
“Histiocytoid” cells in fine‐needle aspirations of papillary carcinoma of the thyroid
A. Renshaw (2002)
10.1159/000363277
Repeat Fine-Needle Aspiration Biopsy within a Short Interval Does Not Increase the Atypical Cytologic Results for Thyroid Nodules with Previously Nondiagnostic Results
H. Lee (2014)
10.1089/105072501750159714
Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
A. Kelman (2001)
10.1002/dc.20990
Papillary thyroid carcinoma with atypical histiocytoid cells on fine‐needle aspiration
M. Harshan (2009)
10.1002/cncy.21631
Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology
W. Faquin (2016)
10.1002/DC.10043
Diagnosis of “follicular neoplasm”: A gray zone in thyroid fine‐needle aspiration cytology
Z. Baloch (2002)
10.1016/j.surg.2014.10.004
Evidence for overestimation of the prevalence of malignancy in indeterminate thyroid nodules classified as Bethesda category III.
M. Iskandar (2015)
10.1186/1742-6413-3-9
Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-Up
M. Deveci (2006)
10.1001/jamaoncol.2016.0386
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Y. Nikiforov (2016)
10.1002/dc.21282
Cystic papillary thyroid carcinoma in fine needle aspiration may represent a subset of the encapsulated variant in WHO classification
G. Yang (2010)
10.1089/thy.2014.0612
The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
K. Strickland (2015)
10.1002/cncr.22955
Fine‐needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations
J. Yang (2007)
10.1089/thy.2015.0020
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
B. Haugen (2016)
10.1016/S0025-6196(11)63360-0
Factors That Predict Malignant Thyroid Lesions When Fine-Needle Aspiration Is “Suspicious for Follicular Neoplasm”
R. Schlinkert (1997)



This paper is referenced by
10.17116/hirurgia202011119
[Optical sonography in differential diagnosis of thyroid nodes].
Z. M. Sigal (2020)
10.1080/00015458.2018.1551769
Risk stratification of the thyroid nodule with Bethesda indeterminate cytology, category III, IV, V on the one surgeon-performed US-guided fine-needle aspiration with 27-gauge needle, verified by histopathology of thyroidectomy: the additional value of one surgeon-performed elastography
Demet Sengul (2019)
10.1111/cyt.12873
The applicability of Papanicolaou Society of Cytopathology system on reporting endoscopic ultrasound‐guided fine needle aspiration cytology specimens of pancreatic lesions in situations with limited availability of ancillary tests. Experience at a single laboratory
Mrinmay Kumar Mallik (2020)
10.1002/dc.24304
Diagnostic utility of cell block in fine needle aspiration cytology of thyroid gland
J. Vance (2019)
10.1002/dc.24639
Developing indicators for quality assurance in cytopathology. Catalan Society of Cytopathology
F. Tresserra (2020)
10.3389/fendo.2019.00438
Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules
Y. Hao (2019)
10.1186/s40463-018-0299-2
Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction
Vince L Biron (2018)
10.1007/s10517-020-04951-1
Somatic Mutations in the BRAF, KRAS, NRAS, EIF1AX, and TERT Genes: Diagnostic Value in Thyroid Neoplasms.
V. A. Kachko (2020)
10.1002/dc.24323
Risk of malignancy and clinical outcomes of cyst fluid only nodules in the thyroid based on ultrasound and aspiration cytology
Risa Kanematsu (2019)
10.1002/cncy.22300
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision‐making from a fine‐needle aspiration sample
J. Krane (2020)
10.1007/s00520-020-05340-0
Ultrasound is superior to palpation for thyroid cancer detection in high-risk childhood cancer and BMT survivors
J. Hess (2020)
10.1002/dc.24170
The influence of thyroid nodule size on the diagnostic efficacy and accuracy of ultrasound guided fine‐needle aspiration cytology
B. Aydoğan (2019)
10.26693/jmbs05.01.360
Morphological Structure of the Thyroid Gland in Conditions of Re-adaptation after Cellular Dehydration Modeling
I. V. Khomenko (2020)
10.1002/dc.24446
Fine needle aspiration cytology of adrenal lesions classified with the Bethesda‐like system: A retrospective study of 484 cases
M. Mustafa (2020)
10.1016/J.JASC.2018.07.004
Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features.
Teklu Legesse (2019)
10.1111/cen.14080
Repeating thyroid fine‐needle aspiration before 3 months may render increased nondiagnostic results
P. Souteiro (2019)
10.1530/EC-19-0262
Circulating adipokines and metabolic setting in differentiated thyroid cancer
C. Mele (2019)
10.1002/dc.24385
The Bethesda System for Reporting Thyroid Cytology (TBSRTC): From look‐backs to look‐ahead
Zubair W Baloch (2020)
10.1002/hed.25968
Isthmusectomy in selected patients with well‐differentiated thyroid carcinoma
Hakyoung Park (2019)
10.3390/cancers12092563
Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
Sena Turkdogan (2020)
10.1002/hed.25520
Fine‐needle aspiration cytology versus core‐needle biopsy for the diagnosis of extracranial head and neck schwannoma
Dongbin Ahn (2018)
10.1186/s13256-019-2113-9
Rheumatoid nodules in thyroid gland parenchyma as an expression of rheumatoid arthritis: a case report
E. Sivridis (2019)
10.3389/fendo.2019.00907
Nodular Thyroid Disease in the Era of Precision Medicine
D. Tumino (2019)
10.1002/cncy.22217
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7‐gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy
C. Bellevicine (2019)
10.4103/cytojournal.cytojournal_53_17
Correlation study of thyroid nodule cytopathology and histopathology at two institutions in Jordan
Niveen I. Abdullah (2018)
10.1002/dc.24526
The diagnosis of primary thyroid lymphoma by fine‐needle aspiration, cell block, and immunohistochemistry technique
C. Huang (2020)
10.1002/pbc.28300
Hurthle cell carcinoma in childhood: A retrospective analysis of five cases and review of pediatric literature
G. Zirilli (2020)
10.1007/978-3-319-28845-1_5071-1
Fine Needle Aspiration (FNA)
Massimo Bongiovanni (2020)
10.1002/cncy.22255
Serous cavity fluids: Momentum, molecules, markers… and more!
Momin T Siddiqui (2020)
10.1007/s13193-020-01053-2
McGill Thyroid Nodule Score in Differentiating Thyroid Nodules in Total Thyroidectomy Cases of Indeterminate Nodules
H. Al-Hakami (2020)
10.1002/dc.24605
Conditions associated with the need for additional needle passes in ultrasound‐guided thyroid fine‐needle aspiration with rapid on‐site pathology evaluation
Ramin Zargham (2020)
10.1002/dc.24676
The impact of repeat fine-needle aspiration in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance: A single center experience.
F. Marin (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar